The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells. ASH 2011.
The IL-3Rα-Targeted Drug SL-401 Selectively Kills Blastic Plasmacytoid Dendritic Cell Neoplasm Cells. ASH 2011. Abstract | Poster
Hodgkin's Lymphoma Cell Lines Have Up-Regulated IL-3 Receptor α (IL-3Rα) Expression and Are Sensitive to SL-401, an IL-3Rα-Targeted Drug
Hodgkin’s Lymphoma Cell Lines Have Up-regulated IL-3 Receptor α (IL-3Rα) Expression and are Sensitive to SL-401, an IL-3Rα-Targeted Drug. ASH 2011. Abstract | Poster